BackInstadose Pharma Overview

Instadose Pharma Intangible Assets

Instadose Pharma's intangible assets is $40M.

Get informed when a big investor buys or sells

+ Follow
Intangible Assets
$40.02M

Peer trimmed avg / median

Loading

Instadose Pharma Intangible Assets History

Loading

Instadose Pharma vs. peers: Intangible Assets Comparison

Loading

Instadose Pharma Intangible Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Instadose Pharma (INSD) FAQ

The latest intangible assets for INSD is $40M as of February 2022. In the prior-year period, the figure was $0. Investors often review this figure alongside Instadose Pharma's historical trend and sector peers before judging valuation or financial health.

Over the past year, INSD's intangible assets moved from $0 to $40M. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Instadose Pharma's operating scale or balance-sheet position.

A intangible assets figure of $40M for INSD is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting INSD's intangible assets ($40M), review year-over-year change from $0, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

Questions & Answers